Screening for hip abnormality in the neonate.

Area of Science:

• Pediatrics
• Orthopedic Surgery
• Diagnostic Imaging

Background:

• International clinical screening policies for hip dysplasia and instability vary significantly.
• Current clinical assessments, including Ortolani and Barlow tests, are performed at birth but have low sensitivity and inconsistent personnel.
• Ultrasonography has emerged as a valuable diagnostic tool since the 1980s, yet its universal versus selective application remains debated.

Purpose of the Study:

• To evaluate the effectiveness of different clinical screening and ultrasonographic assessment policies for hip dysplasia.
• To address the controversy surrounding universal versus selective ultrasonographic screening for hip instability.
• To determine optimal diagnostic and monitoring strategies for hip joint instability.

Main Methods:

• Review of international clinical screening policies for hip dysplasia.
• Analysis of the sensitivity and effectiveness of clinical tests (Ortolani and Barlow).
• Discussion of the role and application of ultrasonography in diagnosing and monitoring hip instability.

Main Results:

• Clinical tests for hip dysplasia have poor sensitivity and are better described as surveillance than screening.
• Controversy exists regarding universal versus selective ultrasonographic screening for hip instability.
• Over-treatment may result from universal ultrasonography, while selective screening might not improve outcomes over clinical methods.

Conclusions:

• Clinically unstable hips require imaging by ultrasound using static and dynamic methods for diagnosis and treatment monitoring.
• Improved and consistent screening protocols are needed to reduce the incidence of late, irreducible hip dislocations.
• The optimal balance between clinical assessment and ultrasonographic imaging for hip dysplasia requires further investigation.